Dear Colleague, 

Do you really understand what it takes to get a drug in the hands of consumers? According to Medscape, only one in every 5,000 to 10,000 drugs that enter preclinical studies will ever make it onto pharmacy shelves.

Biotech Primer's two-day Drug Development Immersion course on Sept. 26-27 in West Windsor, NJ will teach you the regulatory, commercial and scientific considerations required to bring these drugs successfully to market.

Using personal accounts and "war stories," Industry Veteran Joe Quinn will guide you through the decision-making process for both small molecule and biologic products including:

• The importance of patient centricity in drug development
• Regulatory pathways for biologics, biosimilars and orphan drugs
• Target product profiles, what factors into go/no-go decisions
• FDA and EMA desired designations

See full agenda

Who should attend?

This course is designed for individuals who are just entering, or have switched roles, in the biotech and pharmaceutical industries. Additionally, this course is also beneficial for those who work in:

• Finance
• Law
• Marketing
• Business Development
• Clinical Research
• Project Management
• Administrative Support
• Quality Assurance
• Regulatory Affairs
• Manufacturing
• Business Support

Biotech Primer is trusted by the largest names in the biopharma industry, with more than 65,000 professionals trained. Here is a sample of companies that have attended our trainings and what they have said about the courses (scroll down page).

If you can't make this course, take a look at our 2018 course calendar for other courses, dates and locations.
 

Thank you,
Stacey Hawkins
CEO, Biotech Primer
Email me

P.S. Contact me to discuss customized, in-house courses for 15 or more.